Create issue ticket

902 Possible Causes for III, TOPO

Show results in: Italiano

  • Mycoplasma Fermentans

    Although there was heterogeneity among the amounts of GGPL-I or GGPL-III of M. fermentans strains, all of the M. fermentans strains had GGPL-I and/or GGPL-III.[] M. fermentans significantly reduced (by 80%) Topo I activity in the infected/treated tumor cells without affecting the level of Topo I protein.[] Since MF-III-1 distinguishes GGPL-III from GGPL-I, the binding site may include a serinol (2-amino-1,3-propanediol) residue of GGPL-III.[]

  • Oculopharyngeal Muscular Dystrophy

    RESULTS: Clinical features of OPMD were found in all patients in generation II except the youngest sister, and no clinical manifestations were found in generation III.[] The expansion of the PABPN1 polyalanine tract which resulted from 10 to 13 alanines was further confirmed by subcloning into TOPO cloning vectors.[]

  • Metal Dust

    […] exposure in SiMn/FeMn/FeCr smelters had slightly higher health risks than that in FeSi/Si-metal's, (ii) BMI 35 had the highest risk in respiratory infection exacerbations, and (iii[] RESULTS: A neutral or protective haplotype in iSSc anti-topoisomerase I (anti-topo I) responders was found to be a susceptibility haplotype in qSSc patients.[] […] with controls and with iSSc anti-topo I responders (P 0.00004, Pcorr 0.006, OR 11.38, 95% CI 3.17-44.35 and P 0.0002, Pcorr 0.02, OR 30.0, 95% CI 2.05-986, respectively).[]

  • Etoposide

    (PC) in patients with stage III NSCLC.[] The drug is pre-tested and shown to induce topo cleavages using purified human topoisomerase from TopoGEN.[] GA sensitized the cells to etoposide through elevating TOPO 2A with a 2.4 fold rate at 12h.[]

  • Epirubicin

    PATIENTS AND METHODS: HMFEC was a multi-centre, phase III, open label, randomised controlled trial with a 2 2 factorial design.[] Epirubicin Hydrochloride's antitumor actions are mediated by targeting and inhibiting Topo II (topoisomerase II). Literaturhinweise Luck, H.J., et al. 1996. Semin.[] In this multicenter, randomized phase-III trial, node-positive early breast cancer patients were randomly assigned to receive either 6 cycles of FEC (5-fluorouracil 600 mg[]

  • Pseudo-Hurler Polydystrophy

    […] of ML III were joint stiffness of the hands.[] ÍNDICE FACIES "ACHATADA" FACIES "ARREDONDADA" FACIES "ALARGADA" FACIES "TRIANGULAR" FACIES TIPO "MASCARA" FACIES "GROSSEIRA" FACIES "ACHATADA" Ir para o topo da página ACONDROPLASIA[] Abstract We performed a biochemical study on the patient with mucolipidosis III (ML-III, pseudo-Hurler polydystrophy) in Korea.[]

  • Chlortetracycline

    In the pH range of 7.54-8.14, the interaction of the binary complex of Eu(III)/CTC in the presence of trioctyl phosphine oxide (TOPO) occurs at the H20/CCl4 interface, resulting[] III. The effect of benzyl thiocyanate on carbohydrate metabolism of Streptomyces aureofaciens . Fol. microbiol. 9: 96, 1964.[] In the pH range of 7.54-8.14, the interaction of the binary complex of Eu(III)/CTC in the presence of trioctyl phosphine oxide (TOPO) occurs at the H20/CCl4 interface, resulting[]

  • Giardia Lamblia

    Interactions within the giardial ESCRT-III components also differ from those in yeast; while GlVps46a interacts preferentially with Vps24 compared to Vps2, GlVps46b, like[] A putative topoisomerase II (topo II) gene has been identified in the G. lamblia genome. We asked whether Topo II could regulate Giardia encystation.[] […] magnetic resonance, infrared, and mass spectrometry as (i) Oc-1, a mixture of saturated fatty acids C₂₄ to C₂₈; (ii) Oc-2, a mixture of long-chain alcohols C₁₈ to C₂₈; and (iii[]

  • Novobiocin

    In these fibroblast-like cells, the production of type III procollagen was increased and the DNase I hypersensitivity of c-myc gene was reduced.[] […] novobiocin-elicited proteolysis of Topo II and the PMA-induced Topo II phosphorylation, as well as the decrease in Topo II activity and the acquisition of differentiation[] Both of these reagents stimulated the production of procollagen type III peptide, enhanced the cytokeratin assembly and altered the morphological appearance.[]

  • Shigella Flexneri

    […] with the epithelium, the enteric intracellular bacterial pathogen Shigella flexneri invades epithelial cells and escapes intracellular phagosomal destruction using its type III[] The PCR product was transformed into TOPO pCRII (Invitrogen).[] Abstract Bacterial type III secretion machines are widely used to inject virulence proteins into eukaryotic host cells.[]

Further symptoms